Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hematologic Diseases × Interviews as Topic × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 6 Leukemia 2 Disease 2 Colorectal Neoplasms 2 Uterine Cervical Dysplasia 1 Sexually Transmitted Diseases 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oropharyngeal Neoplasms 1 Myelodysplastic Syndromes 1 Motor Activity 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Infertility 1 Hypergammaglobulinemia 1 Hospitalism 1 Hematological Cancer 1 Hematologic Diseases 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Gastrointestinal Stromal Tumors 1 Exanthema 1 Dermatitis, Seborrheic 1 Depression 1 Death 1 Breast Neoplasms 1 Ascites 1

Interventions

isatuximab 2 Dexamethasone 2 pomalidomide 1 Watchful Waiting 1 Vorinostat 1 Specimen Handling 1 Ranitidine 1 Lenalidomide 1 Interviews as Topic 1 Histone Deacetylase Inhibitors 1 Filgrastim 1 Diphenhydramine 1 Data Collection 1 Cyclophosphamide 1 Bortezomib 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03272789 2019-01-23

REBOND

Institut Paoli-Calmettes

Phase NA Unknown

Hematologic Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡